Through the biosurveillance efforts of the UP – Philippine Genome Center (PGC), in coordination with the Department of Health (DOH) – Epidemiology Bureau and the Inter-Agency Task Force (IATF) Task Force on COVID-19 Variants, we report the first confirmed case of the SARS-CoV-2 B.1.1.7 lineage, more commonly known as the UK variant, in the Philippines. An announcement of this finding can be found in an official DOH press release dated January 13, 2021.
PGC SARS-CoV-2 Bulletin No.1: Philippine Genome Center Reports Detection of the D614G Variant of SARS-CoV-2 Virus in the Philippines
COVID-19 or the Coronavirus Disease 2019 is caused by SARS-CoV-2 virus, the genome of which is a single-stranded positive sense RNA that is about 30,000 bases long. It contains 11 genes and several regions have been known to be immunogenic, including different parts of the Spike (S) protein, the Nucleocapsid (N) protein, as well as the Membrane (M) and Envelope (E) proteins, which have therefore been targeted for vaccine development.
PGC Core Facility for Bioinformatics releases six (6) genome sequences of SARS-CoV-2 from Philippine samples between March 22-28, 2020
The Philippine Genome Center (PGC) thru its Core Facility for Bioinformatics (CFB) releases today to the global community through the GISAID database six (6) genomes of the SARS-CoV-2 sequences from Philippine samples taken in Metro Manila between 26 to 28 March 2020.